Pseudomonas aeruginosa: a clinical and genomics update

AC Pelegrin, M Palmieri, C Mirande… - FEMS Microbiology …, 2021 - academic.oup.com
Antimicrobial resistance (AMR) has become a global medical priority that needs urgent
resolution. Pseudomonas aeruginosa is a versatile, adaptable bacterial species with …

The latent tuberculosis cascade-of-care among people living with HIV: A systematic review and meta-analysis

ML Bastos, L Melnychuk, JR Campbell, O Oxlade… - PLoS …, 2021 - journals.plos.org
Background Tuberculosis preventive therapy (TPT) reduces TB-related morbidity and
mortality in people living with HIV (PLHIV). Cascade-of-care analyses help identify gaps and …

Tuberculosis preventive therapy for people living with HIV: A systematic review and network meta-analysis

M Yanes-Lane, E Ortiz-Brizuela, JR Campbell… - PLoS …, 2021 - journals.plos.org
Background Tuberculosis (TB) preventive therapy (TPT) is an essential component of care
for people living with HIV (PLHIV). We compared efficacy, safety, completion, and drug …

Effect of digital medication event reminder and monitor-observed therapy vs standard directly observed therapy on health-related quality of life and catastrophic costs …

T Manyazewal, Y Woldeamanuel, A Fekadu… - JAMA Network …, 2022 - jamanetwork.com
Importance Little is known about whether digital adherence technologies are economical for
patients with tuberculosis (TB) in resource-constrained settings. Objective To test the …

High-dose, short-duration versus standard rifampicin for tuberculosis preventive treatment: a partially blinded, three-arm, non-inferiority, randomised, controlled trial

R Ruslami, F Fregonese, L Apriani, L Barss… - The Lancet …, 2024 - thelancet.com
Background Tuberculosis preventive treatment (TPT) is a key component of tuberculosis
elimination. To improve completion and reduce the burden for people and health systems …

Chapter 6: Tuberculosis preventive treatment in adults

GG Alvarez, C Pease, D Menzies - Canadian Journal of …, 2022 - Taylor & Francis
As Canada moves toward the elimination of tuberculosis (TB), the treatment of latent
tuberculosis infection (LTBI), referred to as tuberculosis preventive treatment (TPT), is …

Impact and benefit-cost ratio of a program for the management of latent tuberculosis infection among refugees in a region of Canada

J Pépin, F Desjardins, A Carignan, M Lambert… - Plos one, 2022 - journals.plos.org
Introduction The identification and treatment of latent tuberculosis infection (LTBI) among
immigrants from high-incidence regions who move to low-incidence countries is generally …

Costs of tuberculosis at 3 treatment centers, Canada, 2010–2016

JR Campbell, P Nsengiyumva… - Emerging Infectious …, 2022 - pmc.ncbi.nlm.nih.gov
We estimated costs of managing different forms of tuberculosis (TB) across Canada by
conducting a retrospective chart review and cost assessment of patients treated for TB …

Four months of rifampicin monotherapy for latent tuberculosis infection in children

CE Oh, D Menzies - Clinical and experimental pediatrics, 2021 - pmc.ncbi.nlm.nih.gov
Diagnosing and treating latent tuberculosis infection (LTBI) is an important part of efforts to
combat tuberculosis (TB). The Korean guidelines for TB published in 2020 recommend 2 …

Isoniazid or rifampicin preventive therapy with and without screening for subclinical TB: a modeling analysis

EA Kendall, H Hussain, A Kunkel, RW Kubiak… - BMC medicine, 2021 - Springer
Background Short-course, rifamycin-based regimens could facilitate scale-up of tuberculosis
preventive therapy (TPT), but it is unclear how stringently tuberculosis (TB) disease should …